Article: Court reinstates Genentech patent lawsuit against Amgen

Article: British Appeals Court Rules against Biotech Giant ...
Knight Ridder/Tribune Business News;  August 1, 2002 ;     700+ words ... ... THOUSAND OAKS, Calif.--A British appeals court dismissed a patent claim by Amgen Inc. on Wednesday, enabling ... erythropoietin, does not encroach on Amgen's patent. Known as Epogen in the United States, Amgen's drug has been among the most ...

Article: APPEALS COURT SIDES WITH AMGEN.(Business)
Daily News (Los Angeles, CA);  January 8, 2003 ;     700+ words ... ... odds favor Thousand Oaks-based Amgen, said a final decision could ... Chao said in a note. Amgen remains confident that it will ... ruling. ``In light of the appeals court's decision, Amgen continues to believe that it ...

Article: U.S. Appeals Court Sides with Amgen in ...
Knight Ridder/Tribune Business News;  January 8, 2003 ;     700+ words ... ... odds favor Thousand Oaks-based Amgen, said a final decision could ... S.," Chao said in a note. Amgen remains confident that it will ... favorable ruling. "In light of the appeals court's decision, Amgen continues to believe that it ...

Article: In U.S. litigation, federal appeals court rules for ...
International Law Update;  January 1, 2003 ;     544 words ... ... manufacturing it. To make EPO, Amgen injects a human gene into hamster ... to pose an immediate threat to Amgen since its adversary has not yet ... Although TTI did win a British appeals court decision over Amgen in an Epogen case in July 2002 ...

Article: Amgen says appeals court confirms Epogen ...
Pharma Marketletter;  January 13, 2003 ;     359 words ... ... epoetin alfa) in the USA. The appeals court affirmed an earlier district ... Aventis had infringed two of Amgen's patents with their rival ... epoetin delta). According to Amgen, the appeals court also vacated the finding of infringement ...

Article: Appeals court rules against Transkaryotic, Aventis. ...
Chain Drug Review;  February 17, 2003 ;     700+ words ... ... OAKS, Calif. -- A federal appeals court has upheld a district court ... Aventis infringed on two of Amgen Corp.'s patents relating ... erythropoietin, or EPO). Amgen asserts that the finding will ... United States. Previously Amgen asserted that it anticipates ...

Article: Ruling renews Neupogen fight. (Digest).(appeals ...
Chain Drug Review;  May 20, 2002 ;     700+ words ...An appeals court has told a U.S. district court to reconsider Genentech Inc.'s lawsuit against Amgen Inc. over technology considered vital ... originally dismissed Genentech's claims that Amgen had infringed on three of its patents ...